October 28, 2022 – The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
"Young men have different testosterone reference ranges than older men," comments lead author Alex Zhu, DO, of University of Michigan, Ann Arbor. "Our findings suggest we should be using age-specific cutoffs when assessing testosterone levels in younger men."
Different thresholds for low testosterone in younger men
Patients with testosterone deficiency have low levels of the male sex hormone testosterone, with related symptoms such as reduced sex drive and erectile dysfunction. Testosterone deficiency is typically regarded as a disease affecting elderly men. However, urologists are seeing a growing number of younger men with concerns related to testosterone deficiency – often with less-specific symptoms such as low energy and fatigue.
Diagnosing low testosterone in young men poses other challenges as well. The standard cutoff point for low testosterone is 300 nanograms per deciliter (300 ng/dL). However, that threshold is based on testosterone studies of older men, and overlooks the normal age-related decline in testosterone levels.
To develop a set of age-specific cutoff points, Dr. Zhu and colleagues from the University of Michigan Department of Urology analyzed data on nearly 1,500 men, aged 20 to 44 years, from a nationwide health study (the National Health and Nutrition Examination Survey, or NHANES). The study excluded men on hormone therapy or those with a history of testicular cancer or testicular removal (orchiectomy). Because of normal daily fluctuations in testosterone levels, the analysis used only morning testosterone measurements.
The range of testosterone levels was evaluated in five-year age groups. The middle tertile (one-third) of the testosterone level distribution in each five-year age group was defined as the normal range. Values below this range were used to calculate age-specific thresholds for low testosterone levels.
As expected, the testosterone levels decreased at older ages. Age specific cutoff points for low testosterone ranged from 409 ng/dL at age 20 to 24 years to 350 ng/dL at age 40 to 44 years – substantially higher than the standard cutoff point. Each one-year increase in age was associated with a 4.3 ng/dL decrease in testosterone level.
Moving away from the ‘one size fits all approach’
The study provides "the first evaluation of normative, population-based testosterone levels for young men in the United States," according to the authors. They note that their study reflects the racial/ethnic diversity of the US population, and doesn't exclude men with health conditions other than testicular cancer or prior orchiectomy.
"In today’s age of personalized medicine, clinicians can now use age-specific testosterone levels to evaluate young men instead of relying on a 'one size fits all' approach," Dr. Zhu and coauthors write. They highlight the need for further studies, including how to interpret age-specific cutoffs in the context of testosterone deficiency symptoms. The researchers also note that the age-specific cutoffs may affect insurance policies – which sometimes do not cover testosterone therapies unless the testosterone level is below the standard 300 ng/dL cutoff.
DOI: 10.1097/JU.0000000000002928
###
About The Journal of Urology®
The Official Journal of the American Urological Association (AUA), and the most widely read and highly cited journal in the field, The Journal of Urology® brings solid coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of urology. This premier journal presents investigative studies on critical areas of research and practice, survey articles providing brief editorial comments on the best and most important urology literature worldwide and practice-oriented reports on significant clinical observations. The Journal of Urology® covers the wide scope of urology, including pediatric urology, urologic cancers, renal transplantation, male infertility, urinary tract stones, female urology and neurourology.
About the American Urological Association
Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has more than 23,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health care policy. To learn more about the AUA visit: www.auanet.org
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
Journal
The Journal of Urology